485 related articles for article (PubMed ID: 1281076)
21. [A new anti-ischemic drug for the treatment of stable effort angina pectoris: nicorandil. Comparison with placebo and isosorbide-5-mononitrate].
Lai C; Onnis E; Solinas R; Orani E; Lai G; Cadeddu M; Cherchi A
Cardiologia; 1991 Sep; 36(9):703-11. PubMed ID: 1839369
[TBL] [Abstract][Full Text] [Related]
22. Selected issues from an overview on nicorandil: tolerance, duration of action, and long-term efficacy.
Wagner G
J Cardiovasc Pharmacol; 1992; 20 Suppl 3():S86-92. PubMed ID: 1282183
[TBL] [Abstract][Full Text] [Related]
23. A double-blind comparison of a beta-blocker and a potassium channel opener in exercise induced angina.
Raftery EB; Lahiri A; Hughes LO; Rose EL
Eur Heart J; 1993 Jul; 14 Suppl B():35-9. PubMed ID: 8370371
[TBL] [Abstract][Full Text] [Related]
24. Pharmacologic therapy of angina pectoris.
Zavecz JH; Bueno O
J La State Med Soc; 1995 May; 147(5):208-10, 213-6. PubMed ID: 7782675
[TBL] [Abstract][Full Text] [Related]
25. Effect of KRN2391, a novel vasodilator, on various experimental anginal models in rats.
Harada K; Fukata Y; Miwa A; Kaneta S; Fukushima H; Ogawa N
Jpn J Pharmacol; 1993 Sep; 63(1):35-9. PubMed ID: 8271529
[TBL] [Abstract][Full Text] [Related]
26. Nicorandil: a review of its use in the management of stable angina pectoris, including high-risk patients.
Simpson D; Wellington K
Drugs; 2004; 64(17):1941-55. PubMed ID: 15329045
[TBL] [Abstract][Full Text] [Related]
27. Comparison of nicorandil and atenolol in stable angina pectoris.
Hughes LO; Rose EL; Lahiri A; Raftery EB
Am J Cardiol; 1990 Sep; 66(7):679-82. PubMed ID: 2144705
[TBL] [Abstract][Full Text] [Related]
28. Comparison of antianginal activity of nicorandil, propranolol and diltiazem with reference to the antianginal mechanism.
Kinoshita M; Hashimoto K; Ohbayashi Y; Inoue T; Taguchi H; Mitsunami K
Am J Cardiol; 1989 Jun; 63(21):71J-74J. PubMed ID: 2525330
[TBL] [Abstract][Full Text] [Related]
29. A controlled single-dose study of the efficacy, dose response and duration of action of nicorandil in angina pectoris.
Camm AJ; Maltz MB
Am J Cardiol; 1989 Jun; 63(21):61J-65J. PubMed ID: 2525328
[TBL] [Abstract][Full Text] [Related]
30. Haemodynamic and clinical effects of an intravenous potassium channel opener--a review.
Kato K
Eur Heart J; 1993 Jul; 14 Suppl B():40-7. PubMed ID: 8370372
[TBL] [Abstract][Full Text] [Related]
31. [Anti-angina activity of potassium-channel activators].
Chiariello M; Duilio C; Ambrosio G
Cardiologia; 1993 Dec; 38(12 Suppl 1):459-63. PubMed ID: 8020048
[TBL] [Abstract][Full Text] [Related]
32. [Selection of therapy with nitrates in patients with stable effort angina: results of comparative study of common isosorbide dinitrate and long acting preparation of isosorbide-5-mononitrate].
Martsevich SIu; Semenova IuE; Alimova EV; Dmitrieva nA; Kozyreva MP; Koniakhina IP; Lukina IuV; Egorov VA
Kardiologiia; 2005; 45(11):42-5. PubMed ID: 16353064
[TBL] [Abstract][Full Text] [Related]
33. Anti-ischemic and anti-anginal effects of controlled-release and conventional isosorbide-5-mononitrate in stable angina pectoris.
Chen YH; Ding PY; Wang SP
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):577-83. PubMed ID: 9830234
[TBL] [Abstract][Full Text] [Related]
34. Antianginal effect of transdermal nitroglycerin and oral nitrates given for 24 hours a day in 2,456 patients with stable angina pectoris. The Italian Multicenter Study.
Savonitto S; Motolese M; Agabiti-Rosei E
Int J Clin Pharmacol Ther; 1995 Apr; 33(4):194-203. PubMed ID: 7620688
[TBL] [Abstract][Full Text] [Related]
35. Coronary dilating effects of intracoronary nicorandil. Comparison with isosorbide dinitrate.
Ejima J; Kaneda K; Moriyama H; Ohmura I; Maruyama T; Kaji Y; Tsuda Y; Kanaya S; Fujino T; Niho Y
Jpn Heart J; 1995 Nov; 36(6):699-707. PubMed ID: 8627976
[TBL] [Abstract][Full Text] [Related]
36. [Characteristics of angina pectoris therapy with nitrates].
Silber S
Herz; 1996 Jun; 21 Suppl 1():4-22. PubMed ID: 8767920
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of isosorbide mononitrate in angina pectoris.
Thadani U; de Vane PJ
Am J Cardiol; 1992 Nov; 70(17):67G-71G. PubMed ID: 1449103
[TBL] [Abstract][Full Text] [Related]
38. Effect of a new coronary vasodilator, nicorandil, on variant angina pectoris.
Kishida H; Murao S
Clin Pharmacol Ther; 1987 Aug; 42(2):166-74. PubMed ID: 2955996
[TBL] [Abstract][Full Text] [Related]
39. Trimetazidine for stable angina pectoris.
Cross HR
Expert Opin Pharmacother; 2001 May; 2(5):857-75. PubMed ID: 11336628
[TBL] [Abstract][Full Text] [Related]
40. The role of nicorandil in the treatment of myocardial ischaemia.
Falase B; Easaw J; Youhana A
Expert Opin Pharmacother; 2001 May; 2(5):845-56. PubMed ID: 11336627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]